Open Access
Case Report
Issue
J Oral Med Oral Surg
Volume 28, Number 2, 2022
Article Number 22
Number of page(s) 6
DOI https://doi.org/10.1051/mbcb/2022010
Published online 26 May 2022
  1. Chan JYK, Gooi Z, Wong EWY, Ng SK, Tong MCF, Vlantis AC. Low-grade myofibroblastic sarcoma: a population-based study. Laryngoscope 2017;127:116–121. [CrossRef] [PubMed] [Google Scholar]
  2. Flucke U, Franchi A. Myofibroblastic sarcoma. In WHO Classification of the Head and Neck Tumours. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. 4th ed. Lyon: International Agency for Research on Cancer, 2017, pp 125–126. [Google Scholar]
  3. Mentzel T, Dry S, Katenkamp D, Fletcher CD. Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumours. Am J Surg Pathol 1998;22:1228–1238. [CrossRef] [PubMed] [Google Scholar]
  4. Ghosh A, Bandopadhyay A, Sarkar R. Low-grade myofibroblastic sarcoma of maxillary sinus and buccal mucosa: two rare cases and review of the literature. Indian J Pathol Microbiol 2019;62:119–121. [CrossRef] [PubMed] [Google Scholar]
  5. Baranov E, Hornick JL. Soft tissue special issue: fibroblastic and myofibroblastic neoplasms of the head and neck. Head Neck Pathol 2020;14:43–58. [CrossRef] [PubMed] [Google Scholar]
  6. Lokuhetty D, White VA, Cree IA. WHO Classification of Tumours. Soft Tissue and Bone Tumours. 5th ed. Lyon: International Agency for Research on Cancer, 2020. pp x. [Google Scholar]
  7. Mentzel TDW. Low-grade myofibroblastic sarcoma. In WHO Classification of Tumours. Soft Tissue and Bone Tumours. Lokuhetty D, White VA, Cree IA. 5th ed. Lyon: International Agency for Research on Cancer, 2020, pp 112–113. [Google Scholar]
  8. Mentzel T. Myofibroblastic sarcomas: a brief review of sarcomas showing a myofibroblastic line of differentiation and discussion of the differential diagnosis. Curr Diagn Pathol 2001;7:17–24. [CrossRef] [Google Scholar]
  9. Goldblum J. An approach to pleomorphic sarcomas: can we subclassify, and does it matter? Mod Pathol 2014;27:S39–S46. [CrossRef] [PubMed] [Google Scholar]
  10. Fisher C. Immunohistochemistry in diagnosis of soft tissue tumours. Histopathology 2011;58:1001–1012. [CrossRef] [PubMed] [Google Scholar]
  11. Cai C, Dehner LP, El-Mofty SK. In myofibroblastic sarcomas of the head and neck, mitotic activity and necrosis define grade: a case study and literature review. Virchows Arch 2013;463:827–836. [Google Scholar]
  12. National Cancer Institute. Inflammatory myofibroblastic tumour. National Institutes of Health (US), 2019. https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/inflammatory-myofibroblastic-tumor (accessed July 29th, 2021). [Google Scholar]
  13. Yamamoto H. Inflammatory myofibroblastic tumour. In WHO Classification of Tumours. Soft Tissue and Bone Tumours. Lokuhetty D, White VA, Cree IA. 5th ed. Lyon: International Agency for Research on Cancer, 2020, pp. 109–113. [Google Scholar]
  14. Cook JR, Dehner LP, Collins MH, Ma Z, Morris SW, Coffin CM. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumour: a comparative immunohistochemical study. Am J Surg Pathol 2001;25:1364–1371. [CrossRef] [PubMed] [Google Scholar]
  15. Solar AA, Jordan RCK. Soft tissue tumors and common metastases of the oral cavity. Periodontol 2000 2011;57:177–197. [CrossRef] [PubMed] [Google Scholar]
  16. Ko E. Primary oral leiomyosarcoma: a systematic review and update. J Oral Pathol Med 2019;48:780–787. [CrossRef] [PubMed] [Google Scholar]
  17. Flucke U, Franchi A. Leiomyosarcoma. In: WHO Classification of the Head and Neck Tumours. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. 4th ed. Lyon: International Agency for Research on Cancer, 2017, pp 35–36. [Google Scholar]
  18. Thway K, Fisher C. Malignant peripheral nerve sheath tumor: pathology and genetics. Ann Diagn Pathol 2014;18:109–116. [CrossRef] [PubMed] [Google Scholar]
  19. Sultan I, Rodriguez-Galindo C, Saab R, Yasir S, Casanova M, Ferrari A. Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983–2005: an analysis of 1268 patients. Cancer 2009;115:3537–3547. [CrossRef] [PubMed] [Google Scholar]
  20. Thway K, Fisher C. Synovial sarcoma: defining features and diagnostic evaluation. Ann Diagn Pathol 2014;18:369–380. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.